drugset / Trial / NCT03831698

Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)

NCT03831698 ↗

Phase 2 Unknown 21 enrolled University of Kansas Medical Center
NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study aimed at assessing the effects of moderate dose omega-3-acid ethyl esters capsules (generic Lovaza) on molecular, and intestinal microbiota changes in participants at high risk for colorectal cancer. The study will be a single arm, open label study.

Timeline

Start
2019-02-06
Primary completion
2022-06-08
Completion
2024-08

Drugs

EvaluationDrugModalityDoseRoute
Subject omega-3 fatty acid ethyl esters Unknown 2 g Oral

Indications